Atteneri Arencibia-Lopez

Santa Cruz De Tenerife, CN 38206, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Synthesis of α,γ-disubstituted-β-hydroxy-γ-lactones and evaluation of their anti-trypanosomatid activities.

Synthesis of α,γ-disubstituted-β-hydroxy-γ-lactones and evaluation of their anti-trypanosomatid activities.

Journal: Bioorganic chemistry

Published: March 05, 2026

Targeting Trypanosoma cruzi with indoles: mechanistic insights and implications for human health and Chagas disease therapy.

Targeting Trypanosoma cruzi with indoles: mechanistic insights and implications for human health and Chagas disease therapy.

Journal: Bioorganic chemistry

Published: October 15, 2025

Leishmanicidal and trypanocidal potential of ß,γ-unsaturated carboxylic acid synthetic derivatives.

Leishmanicidal and trypanocidal potential of ß,γ-unsaturated carboxylic acid synthetic derivatives.

Journal: European journal of medicinal chemistry

Published: September 18, 2025

Unlocking withaferin-A: Structural design toward next-generation antikinetoplastid agents.

Unlocking withaferin-A: Structural design toward next-generation antikinetoplastid agents.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 10, 2025

Laurequinone-based synthetic quinones as agents against Leishmania amazonensis.

Laurequinone-based synthetic quinones as agents against Leishmania amazonensis.

Journal: Bioorganic chemistry

Published: May 27, 2025

Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound.

Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 09, 2025

Repurposing COVID-19 Compounds (via MMV COVID Box): Almitrine and Bortezomib Induce Programmed Cell Death in Trypanosoma cruzi.

Repurposing COVID-19 Compounds (via MMV COVID Box): Almitrine and Bortezomib Induce Programmed Cell Death in Trypanosoma cruzi.

Journal: Pathogens (Basel, Switzerland)

Published: January 15, 2025

Dehydrothyrsiferol Against Cutaneous Leishmaniasis: Treatment Outcome in a Murine Model.

Dehydrothyrsiferol Against Cutaneous Leishmaniasis: Treatment Outcome in a Murine Model.

Journal: Marine drugs

Published: November 14, 2024

E-Cyanoacrylamides and 5-Imino Pyrrolones against Trypanosoma cruzi: Activity and Induced Mechanisms of Cell Death.

E-Cyanoacrylamides and 5-Imino Pyrrolones against Trypanosoma cruzi: Activity and Induced Mechanisms of Cell Death.

Journal: Tropical medicine and infectious disease

Published: July 31, 2024

In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment.

In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment.

Journal: Pathogens (Basel, Switzerland)

Published: July 18, 2024

Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound.

Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 09, 2024

Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis.

Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis.

Journal: International journal for parasitology. Drugs and drug resistance

Published: January 25, 2024

Showing 1-12 of 94

Last Updated: 09/26/2026